1. The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics
   Qiong Li et al, 2022, Cell Death & Disease CrossRef
2. SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K/Akt pathways
   Neslihan Zohrap et al, 2018, Oncotarget CrossRef
3. Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication
   Bing Liu et al, 2019, Life Sciences CrossRef
4. Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?
   Mathilde Mullard et al, 2021, Biochemical Pharmacology CrossRef
5. Ubiquitin-specific protease 1 overexpression indicates poor prognosis and promotes proliferation, migration, and invasion of gastric cancer cells
   Debin Meng et al, 2022, Tissue and Cell CrossRef
6. Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment
   Cassidy M. Van Stiphout et al, 2022, Cancers CrossRef
7. The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival
   Urszula L. McClurg et al, 2018, Oncotarget CrossRef
8. Cellular redox sensor HSCARG negatively regulates the translesion synthesis pathway and exacerbates mammary tumorigenesis
   Weicheng Zang et al, 2019, Proceedings of the National Academy of Sciences CrossRef
9. Insights into the tumor-stromal-immune cell metabolism cross talk in ovarian cancer
   Priscilla W. Tang et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
10. Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
    Urszula L. McClurg et al, 2018, Oncogene CrossRef
11. Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy
    Fangyu Chen et al, 2019, Frontiers in Oncology CrossRef
12. Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma
    Jiaxun Song et al, 2022, Frontiers in Oncology CrossRef
13. USP1 Promotes GC Metastasis via Stabilizing ID2
    Nuoya Li et al, 2021, Disease Markers CrossRef
14. Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5
    Seon Min Woo et al, 2022, Cell Death & Disease CrossRef
15. Regulation of Molecular Targets in Osteosarcoma Treatment
    Betul Celik et al, 2022, International Journal of Molecular Sciences CrossRef
16. Implications of ubiquitination and the maintenance of replication fork stability in cancer therapy
    Donghui Xia et al, 2023, Bioscience Reports CrossRef
17. Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
    Peng Huang et al, 2023, Clinical and Experimental Medicine CrossRef
18. Ubiquitin-specific proteases: Vital regulatory molecules in bone and bone-related diseases
    Wenxin Luo et al, 2023, International Immunopharmacology CrossRef
19. Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics
    Xin Xu et al, 2019, Frontiers in Oncology CrossRef
20. STAT3 and its targeting inhibitors in osteosarcoma
    Yun Liu et al, 2021, Cell Proliferation CrossRef
21. SIK2 represses AKT/GSK3β/β‐catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases
    Xiao‐man Dai et al, 2021, Molecular Oncology CrossRef
22. SIK2: A critical glucolipid metabolic reprogramming regulator and potential target in ovarian cancer
    Dan Hu et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef
23. Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
    Mélanie Lavaud et al, 2021, Cells CrossRef
24. ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells
    Yaxin Sun et al, 2022, Apoptosis CrossRef